Market research
USNA USANA Health Sciences Inc
NYSE USD Consumer Defensive
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 287M
- P/E ratio
- Not available
- Analyst target
- 25
- Dividend yield
- Not available
- Beta
- 0.68
Profile
Instrument facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- ISIN
- Not available
- Market cap
- 287M
- P/E ratio
- Not available
- Analyst target
- 25
- Dividend yield
- Not available
- Beta
- 0.68
About
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Research context
USANA Health Sciences Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the USNA discussion.
5 years, 6 months ago
USANA Health Sciences, Inc is currently in a long term uptrend where the price is trading 11.7% above its 200 day moving average.
From a valuation standpoint, the stock is 98.9% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 1.9.
USANA Health Sciences, Inc's total revenue rose by 318.2% to $1B since the same quarter in the previous year.
Its net income has increased by 478.6% to $178M since the same quarter in the previous year.
Finally, its free cash flow grew by 217.3% to $160M since the same quarter in the previous year.
Based on the above factors, USANA Health Sciences, Inc gets an overall score of 5/5.